Modulation of CD1d-restricted NKT cell responses by CD4

被引:23
作者
Chen, Xiuxu
Wang, Xiaohua
Besra, Gurdyal S.
Gumperz, Jenny E.
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med Microbiol & Immunol, Madison, WI 53705 USA
[2] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
costimulation; cytotoxicity; TCR; CD3; p56(lck); MHC class II;
D O I
10.1189/jlb.0307163
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
CD4(+) and CD4(-) NKT cell populations have been shown to be functionally distinct, but the role of CD4 molecules in NKT cell activation is not clear. Here, we have used human CD1d-restricted NKT cell clones to investigate the contribution of CD4 to NKT cell functional responses. Coligation of CD4 with the TCR/CD3 complex resulted in enhanced cytokine secretion and increased calcium flux by CD4(+) NKT cell clones, indicating that CD4 is functionally active in these cells. CD4 blockade specifically inhibited cytokine secretion and proliferation of CD4(+) NKT cell clones in response to CD1d(+) APCs but did not affect cytotoxicity, suggesting that CD4 preferentially modulates some NKT cell functional responses and not others. Anti-CD4 mAb treatment inhibited NKT cell responses to both MHC class II+ and MHC class II+ APCs, indicating that its effect was not due to blocking CD4 binding to MHC class II molecules on APCs. The inhibitory effect of the anti-CD4 mAb also did not require recognition of CD1d by the NKT cell, since calcium flux was reduced in response to anti-CD3 mAb stimulation. Western blot analysis revealed that anti-CD4 treatment resulted in increased phosphorylation of an inhibitory site of p56(lck) ( tyrosine 505). Thus, CD4 blockade interferes with the course of CD3-mediated signaling events in NKT cells. These results indicate that CD4 can contribute to NKT cell activation independently of the presence of a CD4-ligand on APCs and suggest that it preferentially modulates cytokine and proliferative responses.
引用
收藏
页码:1455 / 1465
页数:11
相关论文
共 58 条
[1]
THE HUMAN P50(CSK) TYROSINE KINASE PHOSPHORYLATES P56(LCK) AT TYR-505 AND DOWN REGULATES ITS CATALYTIC ACTIVITY [J].
BERGMAN, M ;
MUSTELIN, T ;
OETKEN, C ;
PARTANEN, J ;
FLINT, NA ;
AMREIN, KE ;
AUTERO, M ;
BURN, P ;
ALITALO, K .
EMBO JOURNAL, 1992, 11 (08) :2919-2924
[2]
HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC [J].
Bertho, N ;
Drénou, B ;
Laupeze, B ;
Le Berre, C ;
Amiot, L ;
Grosset, JM ;
Fardel, O ;
Charron, D ;
Mooney, N ;
Fauchet, R .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2379-2385
[3]
MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-δ isoenzyme [J].
Bertho, N ;
Blancheteau, VM ;
Setterblad, N ;
Laupeze, B ;
Lord, JM ;
Drénou, B ;
Amiot, L ;
Charron, DJ ;
Fauchet, R ;
Mooney, N .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (08) :935-942
[4]
Detection of a physical and functional interaction between Csk and Lck which involves the SH2 domain of Csk and is mediated by autophosphorylation of Lck on tyrosine 394 [J].
Bougeret, C ;
Delaunay, T ;
Romero, F ;
Jullien, P ;
Sabe, H ;
Hanafusa, H ;
Benarous, R ;
Fischer, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) :7465-7472
[5]
Mechanism of CD1d-restricted natural killer T cell activation during microbial infection [J].
Brigl, M ;
Bry, L ;
Kent, SC ;
Gumperz, JE ;
Brenner, MB .
NATURE IMMUNOLOGY, 2003, 4 (12) :1230-1237
[6]
CD1: Antigen presentation and T cell function [J].
Brigl, M ;
Brenner, MB .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :817-890
[7]
Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors [J].
Brigl, Manfred ;
van den Elzen, Peter ;
Chen, Xiuxu ;
Meyers, Jennifer Hartt ;
Wu, Douglass ;
Wong, Chi-Huey ;
Reddington, Faye ;
Illarianov, Petr A. ;
Besra, Gurdyal S. ;
Brenner, Michael B. ;
Gumperz, Jenny E. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (06) :3625-3634
[8]
Chen HJ, 1997, J IMMUNOL, V159, P2240
[9]
Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules [J].
Chen, Xiuxu ;
Wang, Xiaohua ;
Keaton, Jason M. ;
Reddington, Faye ;
Ilarionov, Petr A. ;
Besra, Gurdyal S. ;
Gumperz, Jenny E. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (10) :6181-6190
[10]
Drénou B, 1999, J IMMUNOL, V163, P4115